Please Note: This trial is no longer enrolling new participants
Maintenance zanzalintinib with oral etoposide following high-dose chemotherapy in patients with relapsed metastatic germ-cell tumor
| Protocol No. | CTO-IUSCCC-0894 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Jennifer King | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
